LIFEPACK CR2 Automated External Defibrillator (AED)
Physio-Control, Inc. · Decision date Sep 29, 2025
What did the FDA decide?
FDA records P170018/S024 as a supplement to PMA P170018, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 29, 2025.
FDA approval order statement
implementation of an additional assembly workstation
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 29, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P170018/S024
- Regulatory pathway
- PMA supplement
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Sep 29, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Physio-Control, Inc.
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P170018/S024 received
Application receipt date recorded by FDA.
P170018/S024 · FDA decision
30-Day Notice
P170018/S023 · Related supplement
LIFEPAK CR2 Automated External Defibrillator
P170018/S025 · Related supplement
LIFEPAK CR2 Defibrillator
Timeline entries are records held by MedtechLedger for P170018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK CR2 Automated External DefibrillatorP170018/S023 | Physio-Control, Inc. | PMA supplement | Nov 6, 2025 | FDA |
LIFEPAK CR2 DefibrillatorP170018/S025 | Physio-Control, Inc. | PMA supplement | Jul 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Physio-Control, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 11811 Willows Rd. NE, Redmond, WA, 98052
Sources and methodology
- Original FDA record: P170018/S024
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

